Real-time disaster intelligence, alerts, and response tools.
Tuesday, March 3, 2026
[ad_1] The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic diseases, which is driving the need for biologics development and production. This upward trend is further […]
[ad_1] RADNOR, Pa., Feb. 3, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (NASDAQ: BIOA) on […]
[ad_1] The high and growing incidence of tuberculosis (TB) cases globally, especially in high-burden countries, is a major driver for both the treatment drugs and diagnostics markets. TB remains a significant public health challenge, with […]
[ad_1] RADNOR, Pa., Jan. 17, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for […]
[ad_1] RADNOR, Pa., Jan. 17, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against MGP Ingredients, Inc. (“MGPI”) (NASDAQ: MGPI) […]
